<DOC>
	<DOCNO>NCT02198716</DOCNO>
	<brief_summary>The treatment complex coronary disease cause limit symptom angina drug-eluting stent technology prove superior bare metal stent technology , respect combine endpoint mortality , MI , requirement target vessel revascularisation severe haemorrhage , patient age 80 .</brief_summary>
	<brief_title>Xience Vision Stent Management Angina Elderly</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>AGE &gt; 80 Stable angina acute coronary syndrome Coronary narrowing suitable stenting either ≥15mm long and/or ≤3mm diameter . Any lesion high risk restenosis eg chronic total occlusion , bifurcation , severe calcification Any leave main stem lesion Acute ST segment elevation myocardial infarction Cardiogenic shock Platelet count =50 x 109/mm3 Patient life expectancy &lt; 1 year Known allergy clopidogrel , aspirin , heparin , stainless steel , IV contrast stent drug elutant Recent major GI haemorrhage ( within 3 month ) Any previous cerebral bleeding episode Participation another investigational drug device study Patient unable give consent Clinical decision preclude use drug elute stent</criteria>
	<gender>All</gender>
	<minimum_age>80 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Percutaneous coronary intervention</keyword>
	<keyword>Elderly</keyword>
	<keyword>Angina</keyword>
</DOC>